Yew-Min Tzeng

Title: Yew-Min Tzeng: Innovator in Pharmaceutical Composition Against SARS-CoV-2

Introduction

Yew-Min Tzeng is a notable inventor based in Taitung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the fight against viral infections. His innovative work has led to the development of a compound that shows promise in treating COVID-19.

Latest Patents

Tzeng holds a patent for the "Use of Ovatodiolide against SARS-CoV-2." This patent describes a pharmaceutical composition that includes a compound known as Ovatodiolide, which is both safe and effective for inhibiting the SARS-CoV-2 virus. The composition is designed to provide a safe and effective amount of Ovatodiolide or its pharmaceutically acceptable salts, combined with a suitable carrier. This invention has great potential for treating COVID-19, showcasing Tzeng's commitment to addressing global health challenges.

Career Highlights

Throughout his career, Yew-Min Tzeng has worked with prestigious institutions, including Peking University and Cns Biotek Corp. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Tzeng has collaborated with notable colleagues such as Zhen Yang and Linqi Zhang. These partnerships have enhanced his research efforts and have been instrumental in the development of his innovative pharmaceutical compositions.

Conclusion

Yew-Min Tzeng is a distinguished inventor whose work in developing a pharmaceutical composition against SARS-CoV-2 highlights his dedication to improving public health. His contributions are vital in the ongoing battle against viral infections, particularly in the context of the COVID-19 pandemic.